Prescription Drug Monitoring Program (PDMP)

The Prescription Drug Monitoring Program (PDMP) is a program developed to promote the public health and welfare by detecting diversion, abuse, and misuse of prescription medications classified as controlled substances under the Alabama Uniform Controlled Substances Act. Under the Code of Alabama, 1975, § 20-2-210, et seq., the Alabama Department of Public Health (ADPH) was authorized to establish, create, and maintain a controlled substances prescription database program. Anyone who dispenses Class II, III, IV, V controlled substances is required to report daily the dispensing of these drugs to the database. 

Goals

The goals of the Alabama Prescription Drug Monitoring Program are:

• To provide a source of information for practitioners and pharmacists regarding the controlled substance use of a patient;
• To reduce prescription drug abuse by providers and patients;
• To reduce time and effort to explore leads and assess the merits of possible drug diversion cases; and
• To educate physicians, pharmacists, policymakers, law enforcement, and the public regarding the diversion, abuse, and misuse of controlled substances.

The Alabama Prescription Drug Monitoring Program is part of the ADPH Pharmacy Division.

2026 Pathways to Prevention

COACH is proud to host the 2026 Pathways to Prevention regional training series, offering a full day of programming for physicians, nurses, pharmacists, social workers, counselors, behavioral health professionals, and more. This year’s series focuses on substance misuse prevention aimed at targeted populations—younger and older adults. Topics include emerging drug trends, communication strategies for youth, naloxone education, stigma reduction, and age-specific prevention skills.

🔗 Register at your preferred location.

📅 April 28 – Mobile, Dauphin Island Sea Lab
📅 April 30 – Auburn, The Red Barn
📅 May 12 – Leeds, Barber Vintage Motorsports Museum
📅 May 14 – Huntsville, Embassy Suites

Featured speakers include:

David Yeager, PhD, is a prominent psychologist and bestselling author known for his research on motivation and adolescent development. He is a professor at the University of Texas at Austin and co-founder of the Texas Behavioral Science and Policy Institute. His most notable work, "10 to 25: The Science of Motivating Young People," explores how to effectively engage and inspire young people, addressing issues such as motivation, mental health, and behavioral problems. Yeager's research has been featured in major publications such as The New York Times and Scientific American, and he has consulted for organizations like Google and the World Bank. 

David Anderson, PhD, is the Vice President of Public Engagement and Education and a senior psychologist in the ADHD and Behavior Disorders Center at the Child Mind Institute. He focuses on expanding our awareness-building and prevention programs while also leading initiatives to build the Child Mind Institute brand, foster strategic partnerships, and forge new relationships with policymakers and youth mental health leaders. Dr. Anderson specializes in evaluating and treating children and adolescents with ADHD and behavior disorders, and he also has broad experience with anxiety and mood disorders. His expertise includes cognitive behavioral therapy (CBT), behavioral parent training, school-based consultation, and classroom behavioral support. 

2026 Substance Misuse Summits

Join Us for the 2026 Substance Misuse Summits!

Dates & Locations

• August 18, 2026 — Mobile, AL at The Grounds
• August 20, 2026 — Huntsville, AL at Jackson Center

*The same programming will be offered at both locations.

Program Details

• 🕣 Check-in begins: 8:30 AM
• 🕘 All-day program
• This activity has been approved for AMA PRA Category 1 Credit(s)™.

Featured Speakers

• Jep Robertson
• Tom Farley
• Laura Stack
• And other national and regional speakers

Registration Links

Mobile – https://cmetracker.net/USAL/Publisher?page=pubOpen#/EventID/124247/

Huntsville – https://cmetracker.net/USAL/Publisher?page=pubOpen#/EventID/124248/

Questions

Please contact us at [email protected] for additional information or assistance.